» Articles » PMID: 37664186

CDK6 is Essential for Mesenchymal Stem Cell Proliferation and Adipocyte Differentiation

Overview
Specialty Biology
Date 2023 Sep 4
PMID 37664186
Authors
Affiliations
Soon will be listed here.
Abstract

Overweight or obesity poses a significant risk of many obesity-related metabolic diseases. Among all the potential new therapies, stem cell-based treatments hold great promise for treating many obesity-related metabolic diseases. However, the mechanisms regulating adipocyte stem cells/progenitors (precursors) are unknown. The aim of this study is to investigate if CDK6 is required for mesenchymal stem cell proliferation and adipocyte differentiation. Cyclin-dependent kinase 6 () mouse models together with stem cells derived from stromal vascular fraction (SVF) or mouse embryonic fibroblasts (MEFs) of mutant mice were used to determine if CDK6 is required for mesenchymal stem cell proliferation and adipocyte differentiation. We found that mice with a kinase inactive CDK6 mutants () had fewer precursor residents in the SVF of adult white adipose tissue (WAT). Stem cells from the SVF or MEFs of mice had defects in proliferation and differentiation into the functional fat cells. In contrast, mice with a constitutively active kinase CDK6 mutant () had the opposite traits. Ablation of RUNX1 in both mature and precursor cells, reversed the phenotypes. These results represent a novel role of CDK6 in regulating precursor numbers, proliferation, and differentiation, suggesting a potential pharmacological intervention for using CDK6 inhibitors in the treatment of obesity-related metabolic diseases.

Citing Articles

Cyclin-dependent kinases (CDKs) are key genes regulating early development of Neptunea arthritica cumingii: evidence from comparative transcriptome and proteome analyses.

Lv F, Ge X, Chang Y, Hao Z BMC Genomics. 2024; 25(1):1221.

PMID: 39701993 PMC: 11660575. DOI: 10.1186/s12864-024-10970-3.

References
1.
Brooks A, Futrega K, Liang X, Hu X, Liu X, Crawford D . Concise Review: Quantitative Detection and Modeling the In Vivo Kinetics of Therapeutic Mesenchymal Stem/Stromal Cells. Stem Cells Transl Med. 2017; 7(1):78-86. PMC: 5746161. DOI: 10.1002/sctm.17-0209. View

2.
Gounari F, Aifantis I, Martin C, Fehling H, Hoeflinger S, Leder P . Tracing lymphopoiesis with the aid of a pTalpha-controlled reporter gene. Nat Immunol. 2002; 3(5):489-96. DOI: 10.1038/ni778. View

3.
Hansen J, Jorgensen C, Petersen R, Hallenborg P, De Matteis R, Boye H . Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation. Proc Natl Acad Sci U S A. 2004; 101(12):4112-7. PMC: 384703. DOI: 10.1073/pnas.0301964101. View

4.
Fujimoto T, Anderson K, Jacobsen S, Nishikawa S, Nerlov C . Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPalpha interaction. EMBO J. 2007; 26(9):2361-70. PMC: 1864973. DOI: 10.1038/sj.emboj.7601675. View

5.
Zhang Y, Li Y, Niepel M, Kawano Y, Han S, Liu S . Targeted deletion of thioesterase superfamily member 1 promotes energy expenditure and protects against obesity and insulin resistance. Proc Natl Acad Sci U S A. 2012; 109(14):5417-22. PMC: 3325675. DOI: 10.1073/pnas.1116011109. View